U.S. FDA advisers recommend inclusion of Omicron component for COVID boosters

1 minute read

Test tube labelled "COVID-19 Omicron variant test positive" is seen in this illustration picture taken January 15, 2022. REUTERS/Dado Ruvic/Illustration

Register now for FREE unlimited access to Reuters.com

June 28 (Reuters) - Advisers to the U.S Food and Drug Administration on Tuesday overwhelmingly recommended the inclusion of an Omicron component for COVID-19 booster vaccines in the fall.

The panel of advisers voted 19-2 in favor of the recommendation.

Register now for FREE unlimited access to Reuters.com
Reporting by Leroy Leo in Bengaluru Editing by Chris Reese

Our Standards: The Thomson Reuters Trust Principles.